[1] |
ZHU Xinping, JIA Di, LIN Shaohui, LIU Chen, LI Jingyi, ZHAO Weiming.
Inhibitory effects of a novel polyoxometalate drug {BiW8O30}on liver cancer SK-HEP-1 cells
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(1): 47-52,66.
|
[2] |
LIU Ning, LIANG Lanlan, LI Shufang, SHEN Xiangchun, LIANG Bing.
Anti-tumor effects of oxymatrine on mouse sarcoma and live cancers in vivo and in vitro
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 426-429,434.
|
[3] |
ZHANG Zongming.
Does thyroid microcarcinoma require surgery
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(5): 325-326.
|
[4] |
SUN Huixin, ZHANG Maoxiang, WANG Wanying, JIA Haihan, SONG Bingbing.
Epidemiological characteristics of prostate cancer in tumor registration areas of the Heilongjiang Province from 2013 to 2017
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(5): 345-348.
|
[5] |
CHENG Shujun.
Aging and malignant tumor─Thought on prevention and control
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(3): 161-162.
|
[6] |
ZHANG Na, FAN Zhilu, YANG Liyan, CHANG Chen, CAI Yan, HAO Jiajie, WANG Mingrong.
Clinical significance of decreased SERPINB5 expression in esophageal squamous cell carcinomas
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(2): 101-109.
|
[7] |
SHI Hailin, HE Tianji, LIU Feng, CAI Menghui, GE Bo.
Prognostic value of TCGA-database mutation burden in muscle-invasive bladder cancers
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 430-437,443.
|
[8] |
JIA Yiyue, MU Gan'en, MENG Xin, SHEN Xiu, ZHOU Zewei, LONG Wei.
Synthesis and antitumor activity in vitro of the two derivatives of disulfiram
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(1): 1-7,14.
|
[9] |
ZHANG Zhiping, SHAN Baoen, SONG Jingjing, WANG Hao, LIU Yingzi, CHEN Wei, GAO Liping, LI Qiaoxia.
Tumorigenic effect of interleukin?17 overexpressing gastric cells in mice
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(4): 295-299.
|
[10] |
WANG Ziyi, ZHANG Lulu, SUN Zhenxiao, LIU Changzhen.
Fludarabine combined with TRAIL induced apoptosis in lung cancer A549 cells
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(3): 203-207.
|
[11] |
MA Ming, JIAO Wenjing, WANG Yanhai, YAN Xi, ZHANG Chao, ZHANG Jinyan.
Clinical values of serum IL-24 and IL-6 concentrations for patients with diffuse large B-cell lymphoma
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(3): 227-230.
|
[12] |
ZHANG Feng, ZHAO Long, FAN Jinping, WU Xueling, MENG Shufang.
Induction of tumor in NIH mice by the plasmid containing the V112A and Q61R mutated HRAS
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(1): 1-8.
|
[13] |
ZHOU Lulin, YANG Runkun, ZHANG Wen, FENG Lin, XIAO Ting, CHENG Shujun, ZHANG Kaitai, ZHANG Lei.
Establishment and optimization of droplet microfluidic single-cell transcriptome detection technology
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(1): 9-14,21.
|
[14] |
CHEN Qiang, JIN Guangyi, LIN Guimiao, LIU Hao, XU Gaixia, WANG Xiaomei.
Biological characteristics of a sperm-tumor cell fusion model
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(3): 221-225.
|
[15] |
LI Qingye, LIU Xiaoling, WU Xiaonen, GUO Ping, CHEN Wen, CHEN Liping.
Histone H3 phosphorylation at Ser10 on maintainence of malignancy in tumor cells
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(2): 81-86,91.
|